[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343751-105":59,"doc-detail-343751-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","glycolysis-regulated-exosomal-linc01214-inhibited-cd8-t-cell-function-and-induced-anti-pd1-resistance-in-melanoma-via-modulating-mir-4492ppp1r11-axis","Glycolysis regulated exosomal LINC01214 inhibited CD8+ T cell function and induced anti-PD1 resistance in melanoma via modulating miR-4492/PPP1R11 axis","","Long non-coding RNAs can be packaged into exosomes to mediate cancer progression and immune suppression, but how exosome-delivered lncRNAs drive CD8+ T cell dysfunction in melanoma and affect PD-1 therapy resistance remains unclear. Circulating LINC01214 was measured in melanoma patients, while exosomes were isolated and characterized, then linked to CD8+ T cell functional changes and a miR-4492/PPP1R11 regulatory mechanism. Melanoma-derived exosomal LINC01214 suppressed IFN-γ, TNF-α, Granzyme-B, and Perforin, promoted PD-1 resistance, and was enhanced by the Warburg effect; targeting it may improve immunotherapy outcomes.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/glycolysis-regulated-exosomal-linc01214-inhibited-cd8-t-cell-function-and-induced-anti-pd1-resistance-in-melanoma-via-modulating-mir-4492ppp1r11-axis/343751/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/glycolysis-regulated-exosomal-linc01214-inhibited-cd8-t-cell-function-and-induced-anti-pd1-resistance-in-melanoma-via-modulating-mir-4492ppp1r11-axis/343751.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How was circulating LINC01214 measured in the study?","Question",{"text":113,"@type":114},"Circulating LINC01214 was detected using quantitative real-time polymerase chain reaction (RT-qPCR).","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What impact did melanoma cell-derived exosomal LINC01214 have on CD8+ T cells?",{"text":118,"@type":114},"It inhibited CD8+ T cell production of IFN-γ, TNF-α, Granzyme-B, and Perforin, leading to CD8+ T cell dysfunction.",{"name":120,"@type":111,"acceptedAnswer":121},"Which molecular pathway links exosomal LINC01214 to PD-1 therapy resistance?",{"text":122,"@type":114},"The study reports that exosomal LINC01214 suppressed CD8+ T cell function by up-regulating PPP1R11 through sponging miR-4492, forming a miR-4492/PPP1R11 regulatory loop that conferred resistance to anti-PD1 therapy.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},343751,1790133565,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Non-coding RNA Research 10 (2025) 242–251  \nContents lists available at ScienceDirect  \nNon-coding RNA Research  \njournal [homepage:](homepage: www.keaipublishing.com/en/journals/non-coding-rna-research)[ www.keaipublishing.com/en/journals/non-coding-rna-research](homepage: www.keaipublishing.com/en/journals/non-coding-rna-research)  \n| Original Research Article\u003Cbr>Glycolysis regulated exosomal LINC01214 inhibited CD8+ T cell function and induced anti-PD1 resistance in melanoma via modulating miR-4492/ PPP1R11 axis |  | |\n| --- | --- | --- |\n| *\u003Cbr>Zhi Ding , Baojin Wu , Junyi Yang , Daohe Wang , Jing Qiao , Fanli Guo\u003Cbr>Department of Plastic Surgery, Huashan Hospital, Fudan University, Shanghai, China |  |  |\n| A R T I C L E I N F O\u003Cbr>Keywords: Melanoma Exosome LINC01214 CD8+ TPD-1 | A B S T R A C T\u003Cbr>Background: Long non-coding RNAs (lncRNAs) can be incorporated into exosomes to mediate the intercellular communication, regulating the occurrence, development, and immunosuppression of cancers. T cell dysfunction has been a hallmark of many cancers, including melanoma, which enables cancer cells escape from host immune surveillance. However, the molecular mechanism of exosome-transmitted lncRNAs in CD8+ T cell dysfunction in melanoma remains largely unclear.\u003Cbr>Method: The expression of circulating LINC01214 (cirLINC01214) was detected by quantitative real-time polymerase chain reaction (RT-qPCR). Exosomes were isolation from the culture medium and plasma of melanoma patients via ultracentrifugation and characterized by transmission electronic microscopy. The regulation of exosomal LINC01214 on CD8+ T cell function was determined by ELISA. The molecular mechanism of exosomal LINC01214 in CD8+ T cells were assessed by the RNA immunoprecipitation and pull-down assay. A mouse model with reconstituted human immune system was used to explore the role of exosomal LINC01214 in the resistance to anti-PD1 therapy.\u003Cbr>Results: LINC01214 was highly expressed in melanoma tissues compared with matched adjacent normal tissues. Increased levels of circulating LINC01214 (cirLINC01214) was observed in melanoma patient plasma and correlated with poor PD-1 immunotherapy response. The cirLINC01214 was predominantly released by melanoma cells in an exosome manner. Melanoma cell-derived exosomal LINC01214 inhibits the production of IFN-γ, TNF-α, Granzyme-B and Perforin by CD8+ T cells. Further mechanism study found that cirLINC01214 delivered by exosomes suppressed CD8+ T cell function by up-regulating the expression of Protein Phosphatase 1 Regulatory Inhibitor Subunit 11 (PPP1R11) through sponging miR-4492. CirLINC01214 conferred resistance to PD-1 immunotherapy in melanoma xenograft mouse model. Melanoma patients with poor prognosis after PD-1 treatment carried high levels of exosomal LINC01214. Additionally, the secretion of exosomal cirLINC01214 was enhanced by the Warburg effect, which was consistent with the reprogrammed glucose metabolism of melanoma.\u003Cbr>Conclusions: Our results demonstrated that exosomal LINC01214 released by melanoma cells promoted immunotherapy resistance by inducing CD8+ T cell dysfunction via the miR-4492/PPP1R11 regulatory loop. Targeting cirLINC01214 might be a potential therapeutic strategy to enhance the outcome of immunotherapy in melanoma. |  |\n\n1. Introduction  \nMelanoma is a kind of tumor caused by the malignant transformation of melanocytes [1,2]. Recently, the incidence of melanoma is steadily increased with a high mortality rate due to its aggressive nature [3]. Immune checkpoint inhibitors and targeted therapies have substantially improved the prognosis of melanoma patients [3]. Notably, application  \nof antibodies targeting the programmed death receptor − 1 (PD-1) has shown promising efficacy and provided long-term clinical benefits inpatients with melanoma [4]. Nevertheless, a major of patients inevitably acquire resistance to PD-1 therapy after several cycles of treatment, which indicates poor prognosis","cbCaik896YVMAs24","https://ap.wps.com/l/cbCaik896YVMAs24","pdf",6001628,"English","# Introduction\n## Background on melanoma and PD-1 resistance\n# Materials and Methods\n## Detection of circulating LINC01214\n## Exosome isolation and characterization\n## Functional and mechanism assays","[{\"question\":\"How was circulating LINC01214 measured in the study?\",\"answer\":\"Circulating LINC01214 was detected using quantitative real-time polymerase chain reaction (RT-qPCR).\"},{\"question\":\"What impact did melanoma cell-derived exosomal LINC01214 have on CD8+ T cells?\",\"answer\":\"It inhibited CD8+ T cell production of IFN-γ, TNF-α, Granzyme-B, and Perforin, leading to CD8+ T cell dysfunction.\"},{\"question\":\"Which molecular pathway links exosomal LINC01214 to PD-1 therapy resistance?\",\"answer\":\"The study reports that exosomal LINC01214 suppressed CD8+ T cell function by up-regulating PPP1R11 through sponging miR-4492, forming a miR-4492/PPP1R11 regulatory loop that conferred resistance to anti-PD1 therapy.\"}]","Glycolysis regulated exosomal LINC01214 inhibited CD8+ T cell function and induced anti-PD1 resistance in melanoma via modulating miR-4492/PPP1R11 axis | PDF",1790052023,25,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61734ffee39df74249b8733777dfa050.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9dca94c885f90d52a8819a73aa7814b9.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a275e5d16d255a13f70cee887550cea1.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e4021ad37467bd89983c465d0e9207f.webp",980,1306]